The relationship between baseline plasma PEDF and nephropathy progression was examined in 1071 subjects, after excluding 39 subjects with less than 2 years of follow-up and 26 subjects with CKD stage 4 or 5. This evidence concerns the gene SERPINF1 and chronic kidney disease.